Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025

ADDEX APPOINTS BANK OF NEW YORK MELLON AS DEPOSITARY BANK

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference

Addex Convenes Annual General Meeting 2025